New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.

Neurosurgical focus

Volumn 20, Issue 4, 2006, Pages

  Dehdashti, Amir R ^a   Hegi, Monika E ^a   Regli, Luca ^a   Pica, Alessia ^a   Stupp, Roger ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; METHYLTRANSFERASE; TEMOZOLOMIDE;

BRAIN TUMOR; CLINICAL TRIAL; DNA METHYLATION; DRUG EFFECT; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; PATIENT SELECTION; REVIEW; STATISTICS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CLINICAL TRIALS; DACARBAZINE; DNA METHYLATION; GLIOBLASTOMA; HUMANS; METHYLTRANSFERASES; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 33747168829     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/foc.2006.20.4.3     Document Type: Review

References (51)